Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Antibodies, Monoclonal, Humanized"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Armuzzi%2C+Alessandro%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
/vufind/Search/Results?lookfor=%22Armuzzi%2C+Alessandro%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
Search /vufind/Search2/Results?lookfor=%22Armuzzi%2C+Alessandro%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
PubPharm (30)
1
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
enthalten in:
BMC gastroenterology
| 2024
von
Peyrin-Biroulet, L.
|
Arkkila, P.
|
Armuzzi, A.
| +14
Wird geladen...
2
Vedolizumab for the Treatment of Chronic Pouchitis
enthalten in:
The New England journal of medicine
| 2023
von
Travis, S.
|
Silverberg, M.
|
Danese, S.
| +45
Wird geladen...
3
The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease
enthalten in:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
| 2023
von
Katsanos, K.
|
Fousekis, F.
|
Armuzzi, A.
CommentOn: Dig Liver Dis. 2023 Feb;55(2):223-229. - PMID 36241535
Wird geladen...
4
Editorial : effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease-the IG-IBD LIVE study. Authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Pugliese, D.
|
Privitera, G.
|
Armuzzi, A.
CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):95-109. - PMID 35876062
Wird geladen...
5
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
enthalten in:
The American journal of gastroenterology
| 2022
von
Onali, S.
|
Pugliese, D.
|
Caprioli, F.
| +28
Wird geladen...
6
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease : the IG-IBD LIVE study
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Pugliese, D.
|
Privitera, G.
|
Crispino, F.
| +58
CommentIn: Aliment Pharmacol Ther. 2022 Aug;56(4):731-732. - PMID 35879894
Wird geladen...
7
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease : a systematic review and meta-analysis
enthalten in:
BMC gastroenterology
| 2022
von
Peyrin-Biroulet, L.
|
Arkkila, P.
|
Armuzzi, A.
| +13
Wird geladen...
8
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease
enthalten in:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
| 2022
von
Pugliese, D.
|
Privitera, G.
|
Schepis, T.
| +6
Wird geladen...
9
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA) : a randomised, double-blind, double-dummy, phase 3 study
enthalten in:
The lancet. Gastroenterology & hepatology
| 2022
von
Danese, S.
|
Colombel, J.
|
Lukas, M.
| +114
CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):2-4. - PMID 34798035
Wird geladen...
10
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY) : a phase 3, randomised, controlled trial
enthalten in:
The lancet. Gastroenterology & hepatology
| 2022
von
Peyrin-Biroulet, L.
|
Hart, A.
|
Bossuyt, P.
| +114
CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):2-4. - PMID 34798035
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Antibodies, Monoclonal, Humanized
Medienart
30
Aufsätze
30
E-Artikel
30
E-Ressourcen
Zeitschriftentitel
5
Digestive and liver disease : official journal ...
3
Inflammatory bowel diseases
2
Alimentary pharmacology & therapeutics
2
BMC gastroenterology
2
Clinical gastroenterology and hepatology : the ...
2
Journal of Crohn's & colitis
2
The New England journal of medicine
2
The lancet. Gastroenterology & hepatology
2
United European gastroenterology journal
1
Annals of medicine
1
Drug design, development and therapy
1
European journal of gastroenterology & hepatology
1
Expert review of clinical immunology
1
Lancet (London, England)
1
Minerva gastroenterologica e dietologica
1
Rheumatology (Oxford, England)
1
The American journal of gastroenterology
Alle anzeigen ...
weniger ...
Thema
Antibodies, Monoclonal, Humanized
24
Journal Article
18
9RV78Q2002
18
vedolizumab
14
Tumor Necrosis Factor-alpha
13
Gastrointestinal Agents
11
B72HH48FLU
11
Infliximab
9
Adalimumab
9
Antibodies, Monoclonal
9
FYS6T7F842
7
Multicenter Study
6
Research Support, Non-U.S. Gov't
6
Review
5
Observational Study
4
3WJQ0SDW1A
4
Anti-Inflammatory Agents
4
Certolizumab Pegol
4
Comment
4
FU77B4U5Z0
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
11
2020-
18
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
30
Englisch
Haven't found what you're looking for?
Wird geladen...